(1)
Ulrich-Pur, H.; Kornek, G. V.; Haider, K.; Kwasny, W.; Payrits, T.; Dworan, N.; Vormittag, L.; Depisch, D.; Lang, F.; Scheithauer, W. Phase II Trial of Pegylated Liposomal Doxorubicin (Caelyxâ„¢) Plus Gemcitabine in Chemotherapeutically Pretreated Patients With Advanced Breast Cancer. AO 2007, 46, 208-213.